Alpha Dna Investment Management LLC Lantheus Holdings, Inc. Transaction History

Alpha Dna Investment Management LLC

  • $261 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$58.87 - $83.05 $301,826 - $425,797
5,127 New
5,127 $411,000
Q2 2023

Jul 31, 2023
SELL
$82.41 - $99.65 $340,023 - $411,155
-4,126 Reduced 31.1%
9,143 $767,000
Q1 2023

May 05, 2023
SELL
$47.76 - $82.86 $415,989 - $721,710
-8,710 Reduced 39.63%
13,269 $1.1 Million
Q4 2022

Jan 27, 2023
BUY
$48.76 - $77.67 $710,774 - $1.13 Million
14,577 Added 196.93%
21,979 $0
Q3 2022

Nov 14, 2022
BUY
$61.42 - $86.29 $454,630 - $638,718
7,402 New
7,402 $520,000

Others Institutions Holding LNTH

# of Institutions
539
Shares Held
69.9M
Call Options Held
651K
Put Options Held
459K
View Full List

About Lantheus Holdings, Inc.

LNTH Quotes by TradingView
  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.63B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email